ACC

This channel contains news about the American College of Cardiology (ACC), including coverage of its annual meeting and links to recently released practice guidelines. The ACC is a leading resource for cardiology professionals, including all its subspecialties. 

News | Heart Failure

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...

Home April 03, 2022
Home
News | Cardiovascular Ultrasound

April 2, 2022 —  Royal Philips, a global leader in health technology, today announced the launch of Ultrasound Workspace ...

Home April 02, 2022
Home
News | Artificial Intelligence

April 2, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance ...

Home April 02, 2022
Home
News | Heart Failure

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

Home April 01, 2022
Home
News | Atrial Fibrillation

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

Home April 01, 2022
Home
News | ACC

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
News | ACC

March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI ...

Home March 31, 2022
Home
News | ACC

March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and ...

Home March 31, 2022
Home
News | ACC

March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio sy ...

Home March 31, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
News | Womens Cardiovascular Health

March 25, 2022 – In the first study to examine differences by sex and race in outcomes following the seven most common ...

Home March 25, 2022
Home
News | Wearables

March 25, 2022 – Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate ...

Home March 25, 2022
Home
News | Heart Failure

March 25, 2022 – Living in a noisy environment can be annoying, but it might also harm your health. People experiencing ...

Home March 25, 2022
Home
News | Heart Failure

March 25, 2022 – Extreme heat accounted for about 600-700 additional deaths from cardiovascular disease annually over a ...

Home March 25, 2022
Home
News | Heart Failure

March 25, 2022 – A heart attack’s impact on the brain may be more serious than previously understood. About 1 in 3 heart ...

Home March 25, 2022
Home
Subscribe Now